Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/dexamethasone-as-a-probe-for-docetaxel-clearance-rLYR9nXxlz
References (23)
-
S. Hoffmeyer, O. Burk, O. Richter, H. Arnold, J. Brockmöller, A. Johne, I. Cascorbi, T. Gerloff, I. Roots, M. Eichelbaum, U. Brinkmann (2000)
Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.Proceedings of the National Academy of Sciences of the United States of America, 97 7
-
R. Bruno, N. Vivier, J. Vergniol, S. Phillips, G. Montay, L. Sheiner (1996)
A population pharmacokinetic model for docetaxel (Taxotere®): Model building and validationJournal of Pharmacokinetics and Biopharmaceutics, 24
-
D. Gentile, E. Tomlinson, J. Maggs, B. Park, Da-Ae Back (1996)
Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation.The Journal of pharmacology and experimental therapeutics, 277 1
-
Noboru Yamamoto, Tomohide Tamura, Yoshikazu Kamiya, I. Sekine, H. Kunitoh, N. Saijo (2000)
Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 11
-
T. Terasawa, T. Okada (1991)
Selenium Dioxide Oxidation of Steroidal 1,4-Dien-3-Ones. A Simple and Convenient Route to 6-HydroxycorticosteroidsSynthetic Communications, 21
-
P. Kuehl, Jiong Zhang, Yvonne Lin, J. Lamba, M. Assem, J. Schuetz, P. Watkins, A. Daly, S. Wrighton, S. Hall, P. Maurel, M. Relling, Cynthia Brimer, K. Yasuda, R. Venkataramanan, S. Strom, K. Thummel, M. Boguski, E. Schuetz (2001)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expressionNature Genetics, 27
-
D. Streetman, J. Bertino, A. Nafziger (2000)
Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.Pharmacogenetics, 10 3
-
I. Cascorbi, T. Gerloff, A. Johne, C. Meisel, S. Hoffmeyer, M. Schwab, E. Schaeffeler, M. Eichelbaum, Ulrich Brinkmann, I. Roots (2001)
Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjectsClinical Pharmacology & Therapeutics, 69
-
Yasuo Kurata, I. Ieiri, M. Kimura, T. Morita, S. Irie, A. Urae, S. Ohdo, H. Ohtani, Y. Sawada, S. Higuchi, K. Otsubo (2002)
Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P‐glycoproteinClinical Pharmacology & Therapeutics, 72
-
M. Shou, Michel Martinet, K. Korzekwa, K. Krausz, F. Gonzalez, H. Gelboin (1998)
Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver.Pharmacogenetics, 8 5
-
Pascale Baille, Ren Bruno, J. Schellens, Lorraine Webster, Michael Millward, J. Verweij, G. Montay, F. Cedex, Experimental Chemotherapy, Pharmacology Laboratory, Peter Maccallum, El W (1997)
Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.Clinical cancer research : an official journal of the American Association for Cancer Research, 3 9
-
S. Urien, J. Barré, C. Morin, A. Paccaly, G. Montay, J. Tillement (2004)
Docetaxel serum protein binding with high affinity to alpha1-acid glycoproteinInvestigational New Drugs, 14
-
W. Loos, S. Baker, J. Verweij, J. Boonstra, A. Sparreboom (2003)
Clinical pharmacokinetics of unbound docetaxel: Role of polysorbate 80 and serum proteinsClinical Pharmacology & Therapeutics, 74
-
B. Goh, Soo-Chin Lee, Lingzhi Wang, L. Fan, Jiayi Guo, J. Lamba, E. Schuetz, R. Lim, H. Lim, A. Ong, How-sung Lee (2002)
Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 17
-
L. Gustavson, L. Benet (1985)
Pharmacokinetics of natural and synthetic glucocorticoids -
J. Lamba, Yvonne Lin, K. Thummel, A. Daly, P. Watkins, S. Strom, Jiong Zhang, E. Schuetz (2002)
Common allelic variants of cytochrome P4503A4 and their prevalence in different populations.Pharmacogenetics, 12 2
-
Beal Sl, L. Sheiner (1982)
Estimating population kinetics.Critical reviews in biomedical engineering, 8 3
-
H. Rosing, V. Lustig, L. Warmerdam, M. Huizing, W. Huinink, J. Schellens, S. Rodenhuis, A. Bult, J. Beijnen (2000)
Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusionCancer Chemotherapy and Pharmacology, 45
-
JoAnn Hirth, P. Watkins, M. Strawderman, A. Schott, R. Bruno, L. Baker (2000)
The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance.Clinical cancer research : an official journal of the American Association for Cancer Research, 6 4
-
L. Zuylen, A. Sparreboom, A. Gaast, M. Burg, V. Beurden, C. Bol, R. Woestenborghs, P. Palmer, J. Verweij (2000)
The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel.Clinical cancer research : an official journal of the American Association for Cancer Research, 6 4
-
J. Vergniol, R. Bruno, G. Montay, A. Frydman (1992)
Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method.Journal of chromatography, 582 1-2
-
L. Zuylen, Jaap Verweij, K. Nooter, Eric Brouwer, G. Stoter, A. Sparreboom (2000)
Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans.Clinical cancer research : an official journal of the American Association for Cancer Research, 6 7
-
L. Rivory, Kellie Slaviero, J. Seale, Janelle Hoskins, Michael Boyer, Philip Beale, Michael Millward, James Bishop, Stephen Clarke (2000)
Optimizing the erythromycin breath test for use in cancer patients.Clinical cancer research : an official journal of the American Association for Cancer Research, 6 9
- Publisher
- Springer Journals
- Copyright
- Copyright © 2004 by Springer-Verlag
- Subject
- Medicine
- ISSN
- 0344-5704
- eISSN
- 1432-0843
- DOI
- 10.1007/s00280-004-0823-0
- pmid
- 15133628
- Publisher site
- See Article on Publisher Site
Abstract
Dexamethasone may be used as a probe to predict docetaxel clearances, hence reducing interindividual variability.
Journal
Cancer Chemotherapy and Pharmacology – Springer Journals
Published: Sep 1, 2004